Comparative Antitumor Effect of Preventive versus Therapeutic Vaccines Employing B16 Melanoma Cells Genetically Modified to Express GM-CSF and B7.2 in a Murine Model
Cancer vaccines have always been a subject of gene therapy research. One of the most successful approaches has been working with genetically modified tumor cells. In this study, we describe our approach to achieving an immune response against a murine melanoma model, employing B16 tumor cells expres...
Main Authors: | Salvador F. Aliño, Maria Sánchez, Rosa Algás, Rafael Botella, Luis Sendra, Antonio Miguel, María José Herrero |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-10-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/4/11/1058 |
Similar Items
-
Antitumor Efficacy of Oncolytic Herpes Virus Type 1 Armed with GM-CSF in Murine Uveal Melanoma Xenografts
by: Liu S, et al.
Published: (2020-11-01) -
Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)
by: Robert J. Soiffer, et al.
Published: (2021-06-01) -
GM-CSF: A Promising Target in Inflammation and Autoimmunity
by: Lee KMC, et al.
Published: (2020-10-01) -
Inter-Tumor Heterogeneity—Melanomas Respond Differently to GM-CSF-Mediated Activation
by: Adi Moshe, et al.
Published: (2020-07-01) -
Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF
by: Hong-Wei Sun, et al.
Published: (2021-02-01)